** Shares of medical device company Hyperfine Inc HYPR.O
down ~15% at $2.29 after the bell
** HYPR says President and CEO Dave Scott will step down
from his roles for personal reasons, effective July 29
urn:newsml:reuters.com:*:nGNX523JDg
** Scott helped HYPR transition to a public co last year
** HYPR names Scott Huennekens, executive chairperson of the
board, as interim President and CEO
** Co says it is engaging in a search for a long-term CEO
** HYPR also reaffirms its full-year 2022 forecast
** Up to Wednesday close, stock had fallen ~63% this year
(Reporting by Ananya Mariam Rajesh in Bengaluru)
((AnanyaMariam.Rajesh@thomsonreuters.com ; Twitter: https://twitter.com/AnanyaMariam))